RETATRUTIDE

MECHANISM

Triple agonist of GLP-1, GIP, and glucagon receptors. Modulates energy homeostasis, adipose tissue metabolism, and insulin sensitivity through complementary receptor pathways.

RESEARCH OVERVIEW

Phase 2 clinical trials demonstrated significant reductions in body weight and improvements in metabolic markers. Research suggests potential applications in metabolic longevity pathways.